gadolinium DTPA

Preferred Label : gadolinium DTPA;

MeSH definition : A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706);

MeSH synonym : gd-dtpa; gadolinium diethylenetriaminepenta acetic acid; dtpa, gadolinium; gadolinium diethylenetriaminepenta-acetic acid; diethylenetriaminepenta-acetic acid, gadolinium; gadopentetic acid; gd dtpa;

CISMeF synonym : 86050-77-3 (Gadopentetate dimeglumine);

MeSH hyponym : gadopentetate dimeglumine; gadolinium DTPA disodium salt; magnevist; magnograf; Dimeglumine, Gadopentetate; Gadolinium DTPA Dimeglumine Salt; Gadolinium DTPA Dimeglumine; Dimeglumine, Gadolinium DTPA; Magnograf Enteral; Magnevist Enteral;

MeSH Related Number : gadolinium DTPA disodium salt; gadopentetate dimeglumine; 80529-93-7 (Gadolinium DTPA); 86050-77-3 (dimeglumine salt); 92923-64-3 (di-Na salt); RH248G8V27;

Registry Number MeSH : 80529-93-7;

Related CAS MeSH : 92923-64-3 (Gadolinium DTPA disodium salt); RH248G8V27 (Gadopentetate dimeglumine);

Wikipedia link : https://en.wikipedia.org/wiki/Gadopentetate dimeglumine;

Is substance : O;

UNII : K2I13DR72L;

InChIKey : IZOOGPBRAOKZFK-UHFFFAOYSA-K;

Details

Origin ID

D019786;

UMLS CUI

C0060933;

ATC code(s)
- gadopentetic acid [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Gadopentetic acid (substance) [SNOMED CT concept]
Pharmacological action(s)
- contrast media [MeSH Descriptor]
Record concept(s)
- gadolinium DTPA [MeSH concept]
- gadolinium DTPA disodium salt [MeSH concept]
- gadopentetate dimeglumine [MeSH concept]
- magnevist [MeSH concept]
- magnograf [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-(3'-(myristoyloxy)propyl)diethylenetriamine-1,4,7,7-tetraacetic acid gadolinium complex [MeSH Supplementary Concept]
- 4-(3'-(myristoyloxy)propyl)-2,6-dioxodiethylenetriamine-1,1,7,7-tetraacetic acid gadolinium complex [MeSH Supplementary Concept]
- 4-(3'-(myristoyloxy)propyl)diethylenetriamine-1,1,7,7-tetraacetic acid gadolinium complex [MeSH Supplementary Concept]
- DAB-Am64-(1B4M-Gd)64 [MeSH Supplementary Concept]
- DTPA-1-hydroxy-3-aminopropane-1,1-diphosphonate [MeSH Supplementary Concept]
- DTPA-4-aminobutane-1,1-diphosphonate [MeSH Supplementary Concept]
- EB-DTPA-Gd [MeSH Supplementary Concept]
- EP3533 [MeSH Supplementary Concept]
- GD-DTPA-Gel-Cis [MeSH Supplementary Concept]
- Gadophrin-3 [MeSH Supplementary Concept]
- Gd(DTPA-BBA) [MeSH Supplementary Concept]
- Gd-DTPA-CNCbl [MeSH Supplementary Concept]
- Gd-DTPA-ST [MeSH Supplementary Concept]
- MP 2269 [MeSH Supplementary Concept]
- N(3),N(6)-bis(2'-myristoyloxyethyl)-1,8-dioxotriethylenetetramine-N,N,N',N'-tetraacetic acid [MeSH Supplementary Concept]
- N(3)-2'-myristoyloxyethyl-N(6)-2'-hydroxyethyl-1,8-dioxotriethylenetetramine-N,N,N',N'-tetraacetic acid [MeSH Supplementary Concept]
- PEG(12000)-Gen4-(Gd DTPA)8 [MeSH Supplementary Concept]
- PEG(3400)-Gen5-(Gd DTPA)13 [MeSH Supplementary Concept]
- PsL-EGFmAb-BSA4-(Gd-DTPA)n [MeSH Supplementary Concept]
- albumin-(gadolinium-DTPA) [MeSH Supplementary Concept]
- bis(gadolinium)-5,10,15,20-tetrakis(4-diethylenetriaminepentaacetamido)phenylporphyrin complex [MeSH Supplementary Concept]
- carboxylmethyl dextran gadopentetate dimeglumine [MeSH Supplementary Concept]
- dextran-(gadolinium-DTPA)15 [MeSH Supplementary Concept]
- gadodiamide [MeSH Supplementary Concept]
- gadolinium diethylene-triamine-pentaacetic acid-bis-oleate [MeSH Supplementary Concept]
- gadolinium diethylenetriamine pentaacetic acid polygalactosyl polylysine [MeSH Supplementary Concept]
- gadolinium diethylenetriaminepentaacetic acid polyethylene glycol [MeSH Supplementary Concept]
- gadolinium ethoxybenzyl DTPA [MeSH Supplementary Concept]
- gadolinium phosphatidylethanolamine-DTPA [MeSH Supplementary Concept]
- gadolinium stearylamide DTPA [MeSH Supplementary Concept]
- gadolinium stearylester DTPA [MeSH Supplementary Concept]
- gadolinium-1-(p-butylbenzyl)-DTPA [MeSH Supplementary Concept]
- gadolinium-DTPA bis-glucosamide [MeSH Supplementary Concept]
- gadolinium-DTPA-mannan [MeSH Supplementary Concept]
- gadolinium-N,N''-bis(3-hydroxy-6-methyl-2-pyridylmethyl)diethylenetriamine-N,N',N''-triacetic acid [MeSH Supplementary Concept]
- gadolinium-diethylenetriaminepentaacetic acid-cascade-polymer [MeSH Supplementary Concept]
- gadopenamide [MeSH Supplementary Concept]
- monomethoxypolyethylene glycol-polylysine-gadolinium DTPA [MeSH Supplementary Concept]
- poly(N-hydroxypropylglutamine)-DTPA-Gd [MeSH Supplementary Concept]
- poly-(Gd-DTPA)-co-(1,6-diaminohexane) [MeSH Supplementary Concept]
- polylysine-(Gd-DTPA) [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing gadopentetate dimeglumine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Gadopentetic Acid [NCIt concept]
- Gadopentetic acid [ICD-11 Extension code]
- Gadopentetic acid (substance) [SNOMED CT concept]
- gadopentetic acid [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients